그림 1. KDIGO 분류에 따른 CKD 위험도 분석 (1) KDIGO 분류 (2) 당뇨유병기간에 따른 KDIGO 위험도 분석
그림 2. 고혈압 유병기간에 따른 특성분석 (1) CKD와 No-CKD 그룹간의 빈도 (2) 고혈압 약제의 사용 특성 (3) 목표치 혈압 (SBP <140, DBP <90) 달성율 (4) 목표치 혈압 달성군과 미달성군의 위험비 분석
표 1. 당뇨병 환자에서 만성신장질환 분류 단계의 임상적 특성
표 2. 만성신장질환에서의 위험요인 분석
References
- KDOQI, "KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease," Am J Kidney Dis, Vol.49, No.2, Suppl.2, pp.S12-154, 2007. https://doi.org/10.1053/j.ajkd.2006.12.005
- P. H. Marathe, H. X. Gao, and K. L. Close, "American Diabetes Association Standards of Medical Care in Diabetes 2017," J Diabetes, Vol.9, No.4, pp.320-324, 2017. https://doi.org/10.1111/1753-0407.12524
- R. Rabkin, "Diabetic nephropathy," Clin Cornerstone, Vol.5, No.2, pp.1-11, 2003. https://doi.org/10.1016/S1098-3597(03)90029-9
- S. L. White, K. R. Polkinghorne, R. C. Atkins, and S. J. Chadban, "Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD -EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study," Am J Kidney Dis, Vol.55, No.4, pp.660-670, 2010. https://doi.org/10.1053/j.ajkd.2009.12.011
- C. A. White, A. Akbari, S. Doucette, D. Fergusson, and G. A. Knoll, "Estimating glomerular filtration rate in kidney transplantation: is the new chronic kidney disease epidemiology collaboration equation any better?," Clin Chem, Vol.56, No.3, pp.474-477, 2010. https://doi.org/10.1373/clinchem.2009.135111
- L. Mihardja, D. Delima, R. G. Massie, M. Karyana, P. Nugroho, and E. Yunir. "Prevalence of kidney dysfunction in diabetes mellitus and associated risk factors among productive age Indonesian," Journal of Diabetes & Metabolic Disorders, Vol.17, No.1, pp.53-61, 2018. https://doi.org/10.1007/s40200-018-0338-6
- L. C. Plantinga, D. C. Crews, J. Coresh, E. R. Miller 3rd, R. Saran, J. Yee, E. Hedgeman, M. Pavkov, M. S. Eberhardt, D. E. Williams, and N. R. Powe. "Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes," Clin J Am Soc Nephrol, Vol.5, No.4, pp.673-682, 2010. https://doi.org/10.2215/CJN.07891109
- L. Mihardja, Delima, H. S. Manz, L. Ghani, and S. Soegondo, "Prevalence and determinants of diabetes mellitus and impaired glucose tolerance in Indonesia (a part of basic health research/Riskesdas)," Acta Med Indones, Vol.41, No.4, pp.169-174, 2009.
- K. H. Ha and D. J. Kim. "Current status of managing diabetes mellitus in Korea," The Korean journal of internal medicine, Vol.31, No.5, p.845, 2016. https://doi.org/10.3904/kjim.2016.253
- A. American Diabetes, "Standards of medical care in diabetes-2015 abridged for primary care providers," Clin Diabetes, Vol.33, No.2, pp.97-111, 2015. https://doi.org/10.2337/diaclin.33.2.97
- P. A. James, S. Oparil, B. L. Carter, W. C. Cushman, C. Dennison-Himmelfarb, J. Handler, D. T. Lackland, M. L. LeFevre, T. D. MacKenzie, O. Ogedegbe, S. C. Smith Jr., L. P. Svetkey, S. J. Taler, R. R. Townsend, J. T. Wright Jr., A. S. Narva, and E. Ortiz, "2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)," JAMA, Vol.311, No.5, pp.507-520, 2014. https://doi.org/10.1001/jama.2013.284427
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)," JAMA, Vol.285, No.19, pp.2486-2497, 2001. https://doi.org/10.1001/jama.285.19.2486
- K. Tziomalos and V. G. Athyros, "Diabetic nephropathy: New risk factors and improve -ments in diagnosis," The review of diabetic studies: RDS, Vol.12, No.1-2, p.110, 2015. https://doi.org/10.1900/RDS.2015.12.110
- K. D. I. G. Outcomes and C. W. Group, "KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease," Kidney Int, Vol.3, No.1, pp.5-14, 2013. https://doi.org/10.1038/kisup.2012.77
- "Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults," Am J Clin Nutr, Vol.68, No.4, pp.899-917, 1998. https://doi.org/10.1093/ajcn/68.4.899
- A. S. Levey, L. A. Stevens, C. H. Schmid, Y. L. Zhang, A. F. Castro 3rd, H. I. Feldman, J. W. Kusek, P. Eggers, F. Van Lente, T. Greene, and J. Coresh, "A new equation to estimate glomerular filtration rate," Ann Intern Med, Vol.150, No.9, pp.604-612, 2009. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
- O. Gheith, N. Farouk, N. Nampoory, M. A. Halim, and T. Al-Otaibi, "Diabetic kidney disease: world wide difference of prevalence and risk factors," Journal of nephropharmacology, Vol.5, No.1, p.49, 2016.
- R. J. MacIsaac, E. I. Ekinci, and G. Jerums, "Markers of and risk factors for the development and progression of diabetic kidney disease," American journal of kidney diseases, Vol.63, No.2, pp.S39-S62, 2014. https://doi.org/10.1053/j.ajkd.2013.10.048
- C. E. Mogensen, "Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes," N Engl J Med, Vol.310, No.6, pp.356-360, 1984. https://doi.org/10.1056/NEJM198402093100605
- A. S. Levey, P. E. de Jong, J. Coresh, M. El Nahas, B. C. Astor, K. Matsushita, R. T. Gansevoort, B. L. Kasiske, and K. U. Eckardt, "The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report," Kidney Int, Vol.80, No.1, pp.17-28, 2011. https://doi.org/10.1038/ki.2010.483
- R. J. Macisaac and G. Jerums, "Diabetic kidney disease with and without albuminuria," Curr Opin Nephrol Hypertens, Vol.20, No.3, pp.246-257, 2011. https://doi.org/10.1097/MNH.0b013e3283456546
- R. A. Bailey, Y. Wang, V. Zhu, and M. F. Rupnow, "Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging," BMC Res Notes, Vol.7, p.415, 2014. https://doi.org/10.1186/1756-0500-7-415
- A. I. Adler, R. J. Stevens, S. E. Manley, R. W. Bilous, C. A. Cull, and R. R. Holman, "Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)," Kidney Int, Vol.63, No.1, pp.225-232, 2003. https://doi.org/10.1046/j.1523-1755.2003.00712.x
- M. Brownlee, "The pathobiology of diabetic complications: a unifying mechanism," Diabetes, Vol.54, No.6, pp.1615-1625, 2005. https://doi.org/10.2337/diabetes.54.6.1615
- "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group," Lancet, Vol.352, No.9131, pp.837-853, 1998. https://doi.org/10.1016/S0140-6736(98)07019-6
- C. Writing Team for the Diabetes, I. Complications Trial/Epidemiology of Diabetes, and G. Complications Research, "Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study," JAMA, Vol.290, No.16, pp.2159-2167, 2003. https://doi.org/10.1001/jama.290.16.2159
- V. Djordjevic, "Hypertension and nephropathy in diabetes mellitus: what is inherited and what is acquired?," Nephrol Dial Transplant, Vol.16 Suppl.6, pp.92-93, 2001. https://doi.org/10.1093/ndt/16.suppl_6.92
- J. Redon, G. Mancia, P. Sleight, H. Schumacher, P. Gao, J. Pogue, R. Fagard, P. Verdecchia, M. Weber, M. Bohm, B. Williams, K. Yusoff, K. Teo, and S. Yusuf, "Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)," J Am Coll Cardiol, Vol.59, No.1, pp.74-83, 2012. https://doi.org/10.1016/j.jacc.2011.09.040
- R. W. Schrier, R. O. Estacio, A. Esler, and P. Mehler, "Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes," Kidney Int, Vol.61, No.3, pp.1086-1097, 2002. https://doi.org/10.1046/j.1523-1755.2002.00213.x
- A. J. Jenkins, T. J. Lyons, D. Zheng, J. D. Otvos, D. T. Lackland, D. McGee, W. T. Garvey, and R. L. Klein, "Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy," Kidney Int, Vol.64, No.3, pp.817-828, 2003. https://doi.org/10.1046/j.1523-1755.2003.00164.x
- V. Harjutsalo and P. H. Groop, "Epidemiology and risk factors for diabetic kidney disease," Adv Chronic Kidney Dis, Vol.21, No.3, pp.260-266, 2014. https://doi.org/10.1053/j.ackd.2014.03.009
- "Abstracts of the 30th Meeting of the European Renal Cell Study Group (ERCSG)," Nephron, Vol.139, No.1, pp.83-111, 2018. https://doi.org/10.1159/000488293
- V. A. Chakkarwar, "Smoking in diabetic nephropathy: sparks in the fuel tank?," World J Diabetes, Vol.3, No.12, pp.186-195, 2012. https://doi.org/10.4239/wjd.v3.i12.186
- O. Of, "Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease," Kidney Int Suppl, Vol.3, No.1, pp.5-14, 2013. https://doi.org/10.1038/kisup.2012.77
- M. Bottomley, M. Bottomley, A. Kalachik, C. Mevada, M. Brook, T. James, and P. Harden, "Single estimated glomerular filtration rate and albuminuria measurement substantially overestimates prevalence of chronic kidney disease," Nephron Clinical Practice, Vol.117, No.4, pp.348-352, 2011.